Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications
- 1 September 2007
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 17 (9), 1035-1045
- https://doi.org/10.1517/13543776.17.9.1035
Abstract
(2007). Inhibitors targeting hepatocyte growth factor receptor and their potential therapeutic applications. Expert Opinion on Therapeutic Patents: Vol. 17, No. 9, pp. 1035-1045. doi: 10.1517/13543776.17.9.1035Keywords
This publication has 32 references indexed in Scilit:
- Invasive growth: a MET-driven genetic programme for cancer and stem cellsNature Reviews Cancer, 2006
- Induction of Hepatocyte Growth Factor/Scatter Factor by Fibroblast Clustering Directly Promotes Tumor Cell InvasivenessCancer Research, 2005
- Second-generation kinase inhibitorsEmerging Therapeutic Targets, 2005
- Trafficking of Normal Stem Cells and Metastasis of Cancer Stem Cells Involve Similar Mechanisms: Pivotal Role of the SDF‐1–CXCR4 AxisThe International Journal of Cell Cloning, 2005
- Met, metastasis, motility and moreNature Reviews Molecular Cell Biology, 2003
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Disassociation of Met-Mediated Biological Responses In Vivo: the Natural Hepatocyte Growth Factor/Scatter Factor Splice Variant NK2 Antagonizes Growth but Facilitates MetastasisMolecular and Cellular Biology, 2000
- Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-METOncogene, 1999
- Mechanism of met oncogene activationCell, 1986
- Molecular cloning of a new transforming gene from a chemically transformed human cell lineNature, 1984